AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Infant Bacterial Therapeutics

Major Shareholding Notification Apr 17, 2020

3162_iss_2020-04-17_9b1b79be-367e-4fd7-b55c-badb626bc6ed.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Infant Bacterial Therapeutics AB

Holder

Swedbank Robur Fonder AB

Instrument

Instrument B-aktier SE0008015259
Before the transaction
Shares 828,986
Voting rights 828,986
Transaction
Reason for major shareholding notification Sell
Date 16/04/2020
Limit for number of votes 5 %
After the transaction
Quantity
Shares 579,172
Directly held voting rights 579,172
Indirectly held voting rights 0
Percentage
Directly held shares 5.16 %
Directly held voting rights 3.96 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 3.96 % 579,172
paragraph, line 2 Instruments - FITA Ch. 4, section 2, first
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Cash settled - Physically settled
Total 3.96 % 579,172
Published
17/04/2020 11:47
Contact
Name Mats Frankeus
Phone 08-58592400 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.